Zhejiang, China

Xinshi Wang

This inventor holds 1 USPTO granted patent. Top assignee: Zhejiang Huahai Pharmaceutical Co., Ltd.. Active years: 2020.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Xinshi Wang

Introduction

Xinshi Wang is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of injectable medications. His work is characterized by a focus on efficiency and product quality.

Latest Patents

Xinshi Wang holds a patent for the "Preparation method of azacitidine for injection." This patent discloses a method where each injection vial contains 100 mg of azacitidine and 100 mg of mannitol. The preparation process involves measuring 80% of the total volume of water for injection at a temperature of 2-6°C, adding mannitol, and stirring until completely dissolved. Azacitidine is then added and stirred to form a solution for injection. The solution is filled into vials, freeze-dried, and packaged after nitrogen filling. This method is advantageous due to its simple process, low energy consumption, high production efficiency, and stable product quality.

Career Highlights

Xinshi Wang is associated with Zhejiang Huahai Pharmaceutical Co., Ltd., where he has contributed to various innovative projects. His expertise in pharmaceutical preparations has positioned him as a valuable asset in the industry.

Collaborations

Xinshi Wang has worked alongside talented colleagues such as Hao Chen and Xiangjie Shi. Their collaborative efforts have further advanced the research and development of pharmaceutical products.

Conclusion

Xinshi Wang's innovative work in the preparation of azacitidine for injection exemplifies his commitment to improving pharmaceutical processes. His contributions continue to impact the industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…